GENESIS Biomed participated in the valuation of CellsIA, a company acquired by Laboratorios ROVI

...

19 June, 2025

Prevention versus Therapy. The breakthrough of the current century

...

12 May, 2025

Convertible Note vs. Capital Increase

...

10 April, 2025

New Pandemics: Are we prepared?

...

20 March, 2025

The data revolution and AI in the Health sector

...

14 November, 2024

Interview Alfons Carnicero -CEO and Co-Founder of ABLE Human Motion

...

24 October, 2024

Interview David Segarra – CEO and Co-Founder of aptaTargets

...

09 October, 2024

Cash Need and Valuation: two key elements for a successful Investment Round

...

26 September, 2024

Biological Sex Differences in Health: Challenges and Opportunities for Personalised Medicine

...

05 September, 2024

What is Open Innovation in pharmaceutical R&D?

...

18 July, 2024